Executive Chairman · PALISADE BIO, INC. (PALI)

Kenneth Carter

A named executive officer of PALISADE BIO in every fiscal year CompBrief holds from FY2019 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,460,472

Salary $133,942Stock awards $0

FY2020: $902,364

1st of 6 named executive officers at Palisade BIO by FY2021 total.

6 named officers on file for PALISADE BIO, FY2021

Kenneth Carter’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PALISADE BIO’s whole pay program stands against its peers

  • PALISADE BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PALI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2022 (DEF 14A).

Free

Get Kenneth Carter’s full pay file as a PDF — free

More than this page: up to 10 years of Kenneth’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Kenneth Carter compensation by year

PALISADE BIO Summary Compensation Table · all 3 fiscal years held
In US dollars, as PALISADE BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021
Salary$395,000$492,500$133,942
Bonus$20,000$0$0
Stock awards$0$0$0
Option awards$425,409$409,864$0
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$0$0$1,326,530
Total$840,409$902,364$1,460,472

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALISADE BIO, INC. DEF 14A filed April 21, 2022, accession 0001193125-22-113172, and prior-year filings. Open the filing on EDGAR.

How this page was built: the PALISADE BIO, INC. filed document, accession 0001193125-22-113172. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2022.

$840K
$902K
$1.5M
FY19
FY20
FY21
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option35,148—$8.50

Per the Outstanding Equity Awards at Fiscal Year-End table in PALISADE BIO, INC.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

PALISADE BIO’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Kenneth Carter · this pageExecutive Chairman$1,460,472
Thomas HallamChief Executive Officer$1,394,867
Matthew KalnikPresident and Chief Operating Officer of Seneca$1,331,633
J.D FinleyChief Financial Officer$1,112,705
Dane SaglioChief Financial Officer of Seneca$997,070
Michael DawsonChief Medical Officer$235,596

The full PALISADE BIO compensation record

free company brief

This page is one person within PALISADE BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALISADE BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kenneth Carter's compensation dossier · One-time report. No refunds.